Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.83 Million | -13.73 Million | -18.64 Million | -9.7 Million | -6.83 Million | -5.37 Million |
| Net Income | -4.31 Million | -33.52 Million | -13.77 Million | 7.15 Million | -15.27 Million | -149.86 Million |
| Depreciation & Amortization | 23.85 Million | 6 Million | 5.47 Million | 4.23 Million | 1.54 Million | 86 Thousand |
| Deferred income taxes | - | -847 Thousand | 8.17 Million | -1.31 Million | -5.04 Million | - |
| Stock-based compensation | - | - | 1.44 Million | 4.09 Million | 6.74 Million | - |
| Change in working capital | -13.96 Million | -2.52 Million | -9.53 Million | -34.01 Million | 3.58 Million | -2.16 Million |
| Other non-cash items | 9.25 Million | 16.3 Million | -2.25 Million | 8.82 Million | -3.43 Million | 146.55 Million |
| Investing Cash Flow | -1.61 Million | 33.04 Million | -28.85 Million | -27.89 Million | -20.3 Million | -13.3 Million |
| Investments in PPE | -866 Thousand | -333 Thousand | -1.53 Million | -13.75 Million | -8.05 Million | -3.89 Million |
| Acquisitions | - | - | 5000.00 | 118 Thousand | -4 Million | - |
| Investment purchases | - | - | -27.22 Million | - | - | - |
| Sales/Maturities of investments | - | 33.89 Million | 27.32 Million | - | - | - |
| Other Investing Activities | -750 Thousand | 33.37 Million | -27.32 Million | -14.14 Million | -8.25 Million | -9.41 Million |
| Financing Cash Flow | -14.92 Million | -19.14 Million | 48.84 Million | 40.22 Million | 28.04 Million | 18.91 Million |
| Debt repayment | -14.22 Million | -29.87 Million | -27.08 Million | -30.98 Million | -4.45 Million | -8.64 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 11.52 Million | 22.55 Million | 46.23 Million | 13.78 Million | 10.25 Million |
| Other Financing Activities | -700 Thousand | 10.72 Million | 21.75 Million | 9.24 Million | 23.58 Million | 10.26 Million |
| Accounts receivables | -4.27 Million | -7.43 Million | 422 Thousand | -1.33 Million | 456 Thousand | -1.76 Million |
| Accounts payables | - | 2.95 Million | -1.14 Million | 2.89 Million | -2.86 Million | 787 Thousand |
| Inventory | -10.5 Million | 3.4 Million | -9.8 Million | -33.17 Million | -4.79 Million | -115 Thousand |
| Other working capital | 817 Thousand | 1.51 Million | -158 Thousand | 499 Thousand | 8.37 Million | -2.04 Million |
| Cash at beginning of period | 5.29 Million | 5.09 Million | 3.75 Million | 1.13 Million | 235 Thousand | - |
| Cash at end of period | 3.59 Million | 5.29 Million | 5.09 Million | 3.75 Million | 1.13 Million | 235 Thousand |
| Capital Expenditure | -866 Thousand | -333 Thousand | -1.53 Million | -13.75 Million | -8.05 Million | -3.89 Million |
| Effect of forex changes on cash | 1000.00 | 32 Thousand | -9000.00 | -5000.00 | - | - |
| Net cash flow / Change in cash | -1.7 Million | 201 Thousand | 1.33 Million | 2.62 Million | 902 Thousand | 235 Thousand |
| Free Cash Flow | 13.96 Million | -14.06 Million | -20.17 Million | -23.45 Million | -14.88 Million | -9.27 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.18 Million | 3.18 Million | -4.31 Million | -4.46 Million | -4.46 Million | 2.3 Million |
| Depreciation & Amortization | 2.87 Million | 2.87 Million | 6.51 Million | 6.17 Million | 819.5 Thousand | 2.43 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.54 Million | -7.54 Million | -13.96 Million | -1.57 Million | -1.57 Million | -5.4 Million |
| Other non-cash items | 3.43 Million | 3.43 Million | 26.59 Million | 4.24 Million | 9.6 Million | 3.69 Million |
| Investing Cash Flow | -430.5 Thousand | -430.5 Thousand | -1.61 Million | -616 Thousand | -616 Thousand | -192 Thousand |
| Investments in PPE | -546 Thousand | -546 Thousand | -866 Thousand | -371 Thousand | -371 Thousand | -62 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 115.5 Thousand | 115.5 Thousand | -750 Thousand | -245 Thousand | -245 Thousand | -130 Thousand |
| Financing Cash Flow | 474.5 Thousand | 474.5 Thousand | -14.92 Million | -3.58 Million | -3.58 Million | -3.87 Million |
| Debt repayment | - | - | -14.22 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 474.5 Thousand | 474.5 Thousand | -700 Thousand | -3.58 Million | -3.58 Million | -3.87 Million |
| Accounts receivables | -974.5 Thousand | -974.5 Thousand | -4.27 Million | -654 Thousand | -654 Thousand | -1.48 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -4.34 Million | -4.34 Million | -10.5 Million | -3.16 Million | -3.16 Million | -2.08 Million |
| Other working capital | -2.22 Million | -2.22 Million | 817 Thousand | 2.24 Million | 2.24 Million | -1.83 Million |
| Cash at beginning of period | - | - | 5.29 Million | - | - | - |
| Cash at end of period | 1.99 Million | 1.99 Million | 3.59 Million | 168 Thousand | 168 Thousand | -1.02 Million |
| Capital Expenditure | -546 Thousand | -546 Thousand | -866 Thousand | -371 Thousand | -371 Thousand | -62 Thousand |
| Effect of forex changes on cash | 5000.00 | 5000.00 | 1000.00 | -12 Thousand | -12 Thousand | 12.5 Thousand |
| Net cash flow / Change in cash | 1.99 Million | 1.99 Million | -1.7 Million | 168 Thousand | 168 Thousand | -1.02 Million |
| Free Cash Flow | 1.4 Million | 1.4 Million | 13.96 Million | 4.01 Million | 4.01 Million | 2.97 Million |
SNSGF
0626
0898
IDL
GOODLUCK
DBSTOCKBRO